Azzad Asset Management Inc /Adv Novartis Ag Transaction History

Azzad Asset Management Inc /Adv

  • $848 Billion
  • Q2 2024

A detailed history of Azzad Asset Management Inc /Adv transactions in Novartis Ag stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 36,383 shares of NVS stock, worth $4.24 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
36,383
Previous 20,284 79.37%
Holding current value
$4.24 Million
Previous $1.96 Billion 97.41%
% of portfolio
0.46%
Previous 0.23%

Shares

54 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$92.57 - $107.37 $1.49 Million - $1.73 Million
16,099 Added 79.37%
36,383 $3.87 Billion
Q1 2024

Apr 19, 2024
BUY
$95.27 - $108.47 $15,338 - $17,463
161 Added 0.8%
20,284 $1.96 Billion
Q4 2023

Apr 01, 2024
BUY
$92.27 - $101.54 $23,436 - $25,791
254 Added 1.28%
20,123 $2.03 Billion
Q3 2023

Apr 01, 2024
SELL
$94.73 - $105.13 $1.37 Million - $1.52 Million
-14,453 Reduced 42.11%
19,869 $2.02 Billion
Q2 2023

Apr 01, 2024
BUY
$92.52 - $104.91 $14,988 - $16,995
162 Added 0.47%
34,322 $3.46 Billion
Q1 2023

Apr 01, 2024
SELL
$80.03 - $92.81 $182,788 - $211,978
-2,284 Reduced 6.27%
34,160 $3.14 Billion
Q4 2022

Apr 01, 2024
SELL
$75.55 - $92.52 $1.1 Million - $1.34 Million
-14,506 Reduced 28.47%
36,444 $3.31 Billion
Q3 2022

Apr 01, 2024
BUY
$74.61 - $87.26 $320,823 - $375,218
4,300 Added 9.22%
50,950 $4.04 Billion
Q2 2022

Apr 01, 2024
BUY
$80.52 - $93.75 $1.26 Million - $1.47 Million
15,668 Added 50.57%
46,650 $3.99 Billion
Q1 2022

Apr 01, 2024
BUY
$80.11 - $90.62 $83,714 - $94,697
1,045 Added 3.49%
30,982 $2.72 Billion
Q4 2021

Apr 01, 2024
BUY
$79.7 - $88.13 $603,408 - $667,232
7,571 Added 33.85%
29,937 $2.62 Billion
Q3 2021

Apr 01, 2024
SELL
$81.78 - $95.14 $537,458 - $625,260
-6,572 Reduced 22.71%
22,366 $1.83 Billion
Q2 2021

Apr 01, 2024
BUY
$85.24 - $94.15 $643,221 - $710,455
7,546 Added 35.27%
28,938 $2.64 Billion
Q1 2021

Apr 01, 2024
BUY
$83.5 - $98.47 $426,017 - $502,393
5,102 Added 31.32%
21,392 $1.83 Billion
Q4 2020

Apr 01, 2024
BUY
$78.07 - $94.43 $38,332 - $46,365
491 Added 3.11%
16,290 $1.54 Billion
Q3 2020

Apr 01, 2024
BUY
$82.14 - $91.0 $63,740 - $70,616
776 Added 5.17%
15,799 $1.37 Billion
Q2 2020

Apr 01, 2024
BUY
$80.93 - $91.1 $328,656 - $369,957
4,061 Added 37.05%
15,023 $1.31 Billion
Q1 2020

Apr 01, 2024
SELL
$70.67 - $99.01 $1.02 Million - $1.43 Million
-14,453 Reduced 56.87%
10,962 $904 Million
Q4 2019

Apr 01, 2024
SELL
$84.35 - $95.37 $421 - $476
-5 Reduced 0.02%
25,415 $2.3 Billion
Q3 2019

Apr 01, 2024
BUY
$85.54 - $94.26 $1.21 Million - $1.33 Million
14,088 Added 124.32%
25,420 $2.22 Billion
Q2 2019

Apr 01, 2024
BUY
$75.4 - $92.8 $104,730 - $128,899
1,389 Added 13.97%
11,332 $1.03 Billion
Q1 2019

Apr 01, 2024
SELL
$75.32 - $86.15 $1,882 - $2,153
-25 Reduced 0.25%
9,943 $956 Million
Q4 2018

Apr 01, 2024
SELL
$73.66 - $82.02 $299,869 - $333,903
-4,071 Reduced 29.0%
9,968 $855 Million
Q3 2018

Apr 01, 2024
SELL
$66.94 - $77.43 $11,647 - $13,472
-174 Reduced 1.22%
14,039 $1.21 Billion
Q2 2018

Apr 01, 2024
BUY
$64.91 - $73.36 $922,565 - $1.04 Million
14,213 New
14,213 $1.07 Billion
Q1 2018

Apr 03, 2024
SELL
$70.39 - $84.15 $9,009 - $10,771
-128 Reduced 0.82%
15,569 $1.26 Billion
Q4 2017

Apr 03, 2024
BUY
$72.33 - $77.64 $23,290 - $25,000
322 Added 2.09%
15,697 $1.32 Billion
Q3 2017

Apr 03, 2024
BUY
$74.14 - $77.27 $20,685 - $21,558
279 Added 1.85%
15,375 $1.32 Billion
Q2 2017

Apr 03, 2024
BUY
N/A
510 Added 3.5%
15,096 $1.26 Billion
Q1 2017

Apr 03, 2024
BUY
N/A
4,274 Added 41.45%
14,586 $1.08 Billion
Q4 2016

Apr 03, 2024
SELL
N/A
-562 Reduced 5.17%
10,312 $751 Million
Q3 2016

Apr 03, 2024
BUY
N/A
831 Added 8.27%
10,874 $859 Million
Q2 2016

Apr 03, 2024
BUY
N/A
1,302 Added 14.9%
10,043 $829 Million
Q1 2016

Apr 03, 2024
BUY
N/A
2,004 Added 29.75%
8,741 $633 Million
Q4 2015

Apr 03, 2024
BUY
N/A
578 Added 9.38%
6,737 $580 Million
Q3 2015

Apr 03, 2024
BUY
N/A
385 Added 6.67%
6,159 $566 Million
Q2 2015

Apr 03, 2024
BUY
N/A
586 Added 11.3%
5,774 $568 Million
Q1 2015

Apr 03, 2024
SELL
N/A
-5,634 Reduced 52.06%
5,188 $512 Million
Q4 2014

Apr 03, 2024
SELL
N/A
-3,282 Reduced 23.27%
10,822 $1 Billion
Q3 2014

Apr 03, 2024
BUY
N/A
457 Added 3.35%
14,104 $1.33 Billion
Q2 2014

Apr 03, 2024
BUY
N/A
339 Added 2.55%
13,647 $1.24 Billion
Q1 2014

Apr 03, 2024
BUY
N/A
586 Added 4.61%
13,308 $1.13 Billion
Q4 2013

Apr 03, 2024
BUY
N/A
226 Added 1.81%
12,722 $1.02 Billion
Q2 2013

Apr 03, 2024
BUY
N/A
63 Added 0.51%
12,496 $959 Million
Q1 2013

Apr 03, 2024
SELL
N/A
-7,690 Reduced 38.21%
12,433 $886 Million
Q4 2012

Apr 08, 2024
BUY
N/A
3,905 Added 46.81%
12,248 $775 Million
Q3 2012

Apr 08, 2024
SELL
N/A
-1,068 Reduced 11.35%
8,343 $511 Million
Q2 2012

Apr 08, 2024
BUY
N/A
169 Added 1.83%
9,411 $526 Million
Q1 2012

Apr 08, 2024
BUY
N/A
5,174 Added 127.19%
9,242 $512 Million
Q4 2011

Apr 08, 2024
SELL
N/A
-1,189 Reduced 22.62%
4,068 $233 Million
Q3 2011

Apr 08, 2024
SELL
N/A
-1,400 Reduced 21.03%
5,257 $293 Million
Q2 2011

Apr 08, 2024
BUY
N/A
1,798 Added 37.0%
6,657 $407 Million
Q1 2011

Apr 08, 2024
SELL
N/A
-1,845 Reduced 27.52%
4,859 $264 Million
Q4 2010

Apr 08, 2024
SELL
N/A
-13,419
6,704 $395 Million

Others Institutions Holding NVS

# of Institutions
1,425
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $251B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email